The incidence of KRAS activation in CRC led us to evaluate with Dr P. Jordan (Lisbon, Portugal) the status of other small GTPases and to identify a novel splice variant of Rac1 overexpressed in human colonic tumors that we designed Rac1b [13]. This evidence concerns the gene KRAS and colorectal carcinoma.